Lipoprotein(a), Cholesterol, Triglyceride Levels, and Vulnerable Coronary Plaques
Top Cited Papers
Abstract
No abstract availableKeywords
This publication has 40 references indexed in Scilit:
- Lipoprotein(a) and Long-Term Plaque Progression, Low-Density Plaque, and Pericoronary InflammationJAMA Cardiology, 2024
- Elevated Lipoprotein(a) as a potential residual risk factor associated with lipid-rich coronary atheroma in patients with type 2 diabetes and coronary artery disease on statin treatment: Insights from the REASSURE-NIRS registryAtherosclerosis, 2022
- Effect of Alirocumab Added to High-Intensity Statin Therapy on Coronary Atherosclerosis in Patients With Acute Myocardial InfarctionJAMA, 2022
- Associations of 26 Circulating Inflammatory and Renal Biomarkers with Near-Infrared Spectroscopy and Long-term Cardiovascular Outcome in Patients Undergoing Coronary Angiography (ATHEROREMO-NIRS Substudy)Current Atherosclerosis Reports, 2018
- Elevated lipoprotein(a) and familial hypercholesterolemia in the coronary care unit: Between Scylla and CharybdisClinical Cardiology, 2018
- Lipoprotein(a) and coronary atheroma progression rates during long-term high-intensity statin therapy: Insights from SATURNAtherosclerosis, 2017
- Effect of Evolocumab on Progression of Coronary Disease in Statin-Treated PatientsJAMA, 2016
- Changes in Plaque Lipid Content After Short-Term Intensive Versus Standard Statin TherapyJACC, 2013
- Low Levels of Low-Density Lipoprotein Cholesterol and Blood Pressure and Progression of Coronary AtherosclerosisJACC, 2009
- Frequency and Predictor of Coronary Thin-Cap Fibroatheroma in Patients With Acute Myocardial Infarction and Stable Angina PectorisJACC, 2008